Enobia Pharma Inc., a developer of novel therapeutics for serious bone disorders, has raised US $40 million through the private placement of approximately 13,724,000 shares of its common stock to new pharmaceutical and...
To Read This Article, Please Login or Subscribe
For $5 plus HST a month (recurring), you will have access to all our premium contents (database access is not included). For database subscription, please click here.
